The Food and Drug Administration says it is developing a plan for how to regulate medical devices that use generative artificial intelligence.
The FDA will eventually release documents spelling out agency policies regarding the technology, Rick Abramson, director of the agency’s Digital Health Center of Excellence, told STAT.
“Our goal is formal policy guidance,” he said in an interview. “The ecosystem is expecting clarity. We seek to provide that clarity, and I’ll also throw in that I think the ecosystem can expect not only broad guidance on the overall topic of generative AI, but also some more narrowly constructed specialty guidance on particular generative AI topics of special interest or special complexity.”
This article is exclusive to STAT+ subscribers #
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? [Log in](/login/)
[View All Plans](https://www.statnews.com/stat-plus/)
source & further reading
statnews.com — original article
STAT+: How health systems are embracing chatbots to query and summarize patient records
Opinion: AI has created a shadow medical system
Opinion: I’m a pediatrician. AI chatbots are grooming my patients